What drove the MLOCT.PA stock jump in pre-market on 13 Jan 2026?

The move was volume-driven — **12,510** shares traded pre-market versus an average **4,963** — suggesting short-term buying. There was no public earnings release; traders reacted to flow and liquidity changes rather than fresh company guidance.

What are the key valuation concerns for MLOCT.PA?

Valuation concerns include negative EPS (**-€0.04**), a negative P/E, price-to-sales at **461.77**, and a low current ratio **0.31**, which signal limited short-term liquidity and high valuation pressure relative to revenues.

What price targets and upside does Meyka AI show for MLOCT.PA stock?

Meyka AI's model projects a 12-month figure of **€0.297**, implying **56.32%** upside from **€0.19**. Short-term resistance is near **€0.236** and a medium-term target of **€0.30** is used as a cautious reference; forecasts are not guarantees.

How should traders manage risk with MLOCT.PA on EURONEXT?

Use tight position sizing and watch liquidity: the stock’s float is small and volatility is high. Set stop-losses below recent support and confirm any continued volume above **4,963** before increasing exposure.

EU Stocks

MLOCT.PA Octopus Biosafety (EURONEXT) pre-market up 18.75% on 13 Jan 2026: watch volume

ByHuzaifa Zahoor January 13, 2026January 13, 2026

The MLOCT.PA stock jumped in pre-market trade on 13 Jan 2026 after a spike in buying interest, trading at €0.19, up 18.75% from the prior close of €0.16. Volume in the session reached 12,510 shares versus an average of 4,963, pushing the relative volume to 2.52x. Octopus Biosafety SA (MLOCT.PA) is listed on EURONEXT and designs decontamination and biosafety robots used across transport, defence and agro-food. We examine what moved the price, the financial backdrop and short-term targets for traders watching the top-gainer move in Europe’s pre-market